Suntar Eco-City Inkomsten in het verleden
Verleden criteriumcontroles 1/6
Suntar Eco-City has been growing earnings at an average annual rate of 12.9%, while the Healthcare industry saw earnings growing at 5.8% annually. Revenues have been growing at an average rate of 37.7% per year. Suntar Eco-City's return on equity is 0.8%, and it has net margins of 2.5%.
Belangrijke informatie
12.9%
Groei van de winst
12.9%
Groei van de winst per aandeel
| Healthcare Groei van de industrie | 9.7% |
| Inkomstengroei | 37.7% |
| Rendement op eigen vermogen | 0.8% |
| Nettomarge | 2.5% |
| Laatste winstupdate | 30 Jun 2024 |
Recente prestatie-updates uit het verleden
Opbrengsten en kosten
Hoe Suntar Eco-City geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.
Inkomsten en omzetgeschiedenis
| Datum | Inkomsten | Inkomsten | G+A Uitgaven | R&D-uitgaven |
|---|---|---|---|---|
| 30 Jun 24 | 28 | 1 | 4 | 0 |
| 31 Mar 24 | 32 | 1 | 4 | 0 |
| 31 Dec 23 | 35 | 1 | 4 | 0 |
| 30 Sep 23 | 30 | 1 | 4 | 0 |
| 30 Jun 23 | 25 | 1 | 3 | 0 |
| 31 Mar 23 | 21 | 1 | 3 | 0 |
| 31 Dec 22 | 16 | 0 | 3 | 0 |
| 30 Sep 22 | 11 | 0 | 3 | 0 |
| 30 Jun 22 | 6 | 0 | 4 | 0 |
| 31 Mar 22 | 8 | 0 | 4 | 0 |
| 31 Dec 21 | 11 | 0 | 4 | 0 |
| 30 Sep 21 | 15 | 0 | 4 | 0 |
| 30 Jun 21 | 18 | 0 | 4 | 0 |
| 31 Mar 21 | 20 | 0 | 4 | 0 |
| 31 Dec 20 | 22 | 0 | 4 | 0 |
| 30 Sep 20 | -7 | 3 | -2 | 0 |
| 30 Jun 20 | 7 | 5 | 0 | 0 |
| 31 Mar 20 | 6 | 1 | 2 | 0 |
| 31 Dec 19 | 3 | 0 | 3 | 0 |
| 30 Sep 19 | 6 | 0 | 4 | 0 |
| 30 Jun 19 | -3 | -3 | 4 | 0 |
| 31 Mar 19 | 30 | -14 | 11 | 0 |
| 31 Dec 18 | 9 | -1 | 4 | 0 |
| 30 Sep 18 | 45 | -21 | 14 | 0 |
| 30 Jun 18 | 42 | -20 | 13 | 0 |
| 31 Mar 18 | 40 | -19 | 12 | 0 |
| 31 Dec 17 | 44 | -17 | 12 | 0 |
| 30 Sep 17 | 54 | 3 | 7 | 0 |
| 30 Jun 17 | 52 | 5 | 7 | 0 |
| 31 Mar 17 | 49 | 3 | 7 | 0 |
| 31 Dec 16 | 35 | 1 | 8 | 0 |
| 30 Sep 16 | 17 | -5 | 9 | 0 |
| 30 Jun 16 | 23 | -6 | 9 | 0 |
| 31 Mar 16 | 23 | -5 | 8 | 0 |
| 31 Dec 15 | 32 | -5 | 8 | 0 |
| 30 Sep 15 | 33 | -7 | 11 | 0 |
| 30 Jun 15 | 23 | -8 | 12 | 0 |
| 31 Mar 15 | 18 | -9 | 10 | 0 |
| 31 Dec 14 | 10 | -8 | 10 | 0 |
| 30 Sep 14 | 14 | 0 | 7 | 0 |
| 30 Jun 14 | 19 | 1 | 5 | 0 |
| 31 Mar 14 | 28 | 0 | 8 | 0 |
| 31 Dec 13 | 41 | 0 | 9 | 0 |
Kwaliteitswinsten: BKZ has a large one-off loss of CN¥330.0K impacting its last 12 months of financial results to 30th June, 2024.
Groeiende winstmarge: BKZ's current net profit margins (2.5%) are lower than last year (4.6%).
Analyse vrije kasstroom versus winst
Analyse van de winstgroei in het verleden
Winsttrend: BKZ has become profitable over the past 5 years, growing earnings by 12.9% per year.
Versnelling van de groei: BKZ's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Winst versus industrie: BKZ had negative earnings growth (-40.4%) over the past year, making it difficult to compare to the Healthcare industry average (-35.5%).
Rendement op eigen vermogen
Hoge ROE: BKZ's Return on Equity (0.8%) is considered low.